Stereochemistry of 1,5-benzothiazepin-4-one S-oxide: insight into the stereogenic elements at the sulfur atom and axis.

Oxidation of 1,5-benzothiazepin-4-one (5-A) stereoselectively afforded the S-oxide 8I-A (aS,1S) in preference to the diastereomer 8II-A (aS,1R) affected by the remote stereogenic axis. All the enantiomers (8I-A/8I-B and 8II-A/8II-B) were separated and isolated, and the interconversion between 8I and 8II (equilibrium ratio ≈5:1) was unequivocally verified to be caused by the rotation around the axis.

[1]  Hideyo Takahashi,et al.  Active conformation of seven-membered-ring benzolactams as new ACAT inhibitors: latent chirality at N5 in the 1,5-benzodiazepin-2-one nucleus. , 2012, Chemistry.

[2]  Hideyo Takahashi,et al.  Isolation and characterization of atropisomers of seven-membered-ring benzolactams. , 2011, The Journal of organic chemistry.

[3]  Hideyo Takahashi,et al.  Atropisomerism in the vaptan class of vasopressin receptor ligands: the active conformation recognized by the receptor. , 2011, Angewandte Chemie.

[4]  O. Hucke,et al.  Revealing Atropisomer Axial Chirality in Drug Discovery , 2011, ChemMedChem.

[5]  Hideyo Takahashi,et al.  Atropisomerism observed in indometacin derivatives. , 2011, Organic letters.

[6]  S. LaPlante,et al.  The challenge of atropisomerism in drug discovery. , 2009, Angewandte Chemie.

[7]  Rachel A. Garlish,et al.  Atropisomeric small molecule Bcl-2 ligands: determination of bioactive conformation. , 2009, Bioorganic & medicinal chemistry letters.

[8]  Anamik Shah,et al.  1,5-Benzothiazepine, a versatile pharmacophore: a review. , 2008, European journal of medicinal chemistry.

[9]  Hideyo Takahashi,et al.  Axial chirality and affinity at the GABA(A) receptor of pyrimido[1,2-a][1,4]benzodiazepines and related compounds. , 2008, Bioorganic & medicinal chemistry.

[10]  Hideyo Takahashi,et al.  Atropisomeric properties of the dibenzo[b,d]azepin-6-one nucleus. , 2008, Organic letters.

[11]  R. J. Abraham,et al.  1H chemical shifts in NMR. Part 27 : proton chemical shifts in sulfoxides and sulfones and the magnetic anisotropy, electric field and steric effects of the SO bond , 2008, Magnetic resonance in chemistry : MRC.

[12]  T. Potter,et al.  Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties. , 2007, Journal of medicinal chemistry.

[13]  D. Curran,et al.  Relaying asymmetry of transient atropisomers of o-iodoanilides by radical cyclizations. , 2005, Journal of the American Chemical Society.

[14]  Daniel C. Hill,et al.  Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity. , 2002, Journal of medicinal chemistry.

[15]  T. Steiner.  The hydrogen bond in the solid state. , 2002, Angewandte Chemie.

[16]  C. Rosini,et al.  Towards a correlation of absolute configuration and chiroptical properties of alkyl aryl sulfoxides: a coupled-oscillator foundation of the empirical Mislow rule? , 2001, Chemistry.

[17]  A. Fujishima,et al.  Axially chiral 1,7-naphthyridine-6-carboxamide derivatives as orally active tachykinin NK(1) receptor antagonists: synthesis, antagonistic activity, and effects on bladder functions. , 1999, Journal of medicinal chemistry.

[18]  K. Kövér,et al.  Oxazepines and thiazepines, 36. Diastereoselective sulfoxidation of 2,3- dihydro-1,5-benzothiazepin-4(5H)-ones by dimethyldioxirane , 1999 .

[19]  E. Novellino,et al.  Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity. , 1996, Journal of medicinal chemistry.

[20]  R. DeVita,et al.  Heterocyclic analogs of the benzolactam nucleus of the non-peptidic growth hormone secretagogue L-692,429 , 1995 .

[21]  P. Mui,et al.  elastase inhibitors containing conformationally restricted lactams as P3-P2 dipeptide replacements , 1993 .

[22]  D. Seebach,et al.  Herstellung enantiomerenreiner Sulfoxide aus Milchsäure und 3-Hydroxybuttersäure: Isopropenyl-tolyl-sulfoxid und 2-(Phenylsulfinyl) acrylester , 1992 .

[23]  M. Kori,et al.  Synthesis and angiotensin converting enzyme inhibitory activity of 1,5-benzothiazepine and 1,5-benzoxazepine derivatives. I. , 1986, Chemical & pharmaceutical bulletin.

[24]  J. Stanton,et al.  Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives. , 1985, Journal of medicinal chemistry.

[25]  S. Takeo,et al.  Synthesis of 1,5-Benzothiazepine Derivatives. III , 1971 .

[26]  K. Mislow,et al.  Thermal racemization of diaryl, alkyl aryl, and dialkyl sulfoxides by pyramidal inversion , 1968 .

[27]  K. Mislow,et al.  Synthesis and absolute configuration of optically active phosphine oxides and phosphinates , 1968 .

[28]  E. Miller,et al.  Thermal racemization of benzyl p-tolyl sulfoxide and thermal rearrangement of benzyl p-toluenesulfenate , 1968 .

[29]  E. Miller,et al.  Thermal racemization of allylic sulfoxides and interconversion of allylic sulfoxides and sulfenates. Mechanism and stereochemistry , 1968 .

[30]  K. Mislow,et al.  Absolute configuration of sulfoxides and sulfinates , 1968 .

[31]  J. Piala,et al.  Syntheses and pharmacological acitivity of compounds related to the antidepressant, 5-(2-dimethylaminoethyl)-2,3-dihydro-2-phenyl-1,5-benzothiazepin-4(5H)-one(thiazesim). 3. , 1968, Journal of medicinal chemistry.

[32]  J. Krapcho,et al.  Substituted 2,3-dihydro-1,5-benzothiazepin-4(5H)-one and related compounds. II. A new class of antidepressants. , 1966, Journal of medicinal chemistry.

[33]  Martin Karplus,et al.  Vicinal Proton Coupling in Nuclear Magnetic Resonance , 1963 .

[34]  J. Krapcho,et al.  SUBSTITUTED 2,3-DIHYDRO-1,5-BENZOTHIAZEPIN-4(5H)-ONES AND 3,4-DIHYDRO-2-PHENYL-(2H)-1,6-BENZOTHIAZOCIN-5(6H)-ONES. , 1963, Journal of medicinal chemistry.